Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 5, 2007, Pages 913-918

  Sundqvist, Martin ^a,b   Kahlmeter, Gunnar ^a,b  

^a CENTRAL HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antimicrobial resistance; Skin and soft tissue infections; Surveillance; Urinary tract infections

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFADROXIL; CIPROFLOXACIN; CLINDAMYCIN; FUSIDIC ACID; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC ALGORITHM; GENETIC DATABASE; NONHUMAN; SKIN INFECTION; SOFT TISSUE INFECTION; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

ALGORITHMS; DATABASES, FACTUAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 34447563649     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm040     Document Type: Article

References (20)

1. Magee JT. Effects of duplicate and screening isolates on surveillance of community and hospital antibiotic resistance. J Antimicrob Chemother 2004; 54: 155-62.
2. Rodriguez JC, Sirvent E, Lopez-Lozano JM et al. Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies. J Antimicrob Chemother 2003; 52: 132-4.
3. Shannon KP, French GL. Antibiotic resistance: Effect of different criteria for classifying isolates as duplicates on apparent resistance frequencies. J Antimicrob Chemother 2002; 49: 201-4.
4. Shannon KP, French GL. Validation of the NCCLS proposal to use results only from the first isolate of a species per patient in the calculation of susceptibility frequencies. J Antimicrob Chemother 2002; 50 965-9.
5. Huovinen P. Recording of antimicrobial resistance of urinary tract isolates - effect of repeat samples on resistance levels. J Antimicrob Chemother 1985; 16: 443-7.
6. Bennett WP, O'Connor ML, Wasilauskas BL. A comparison of antibiotic susceptibility profiles using single and multiple isolates per patient. Infect Control 1985; 6: 157-60.
7. Horvat RT, Klutman NE, Lacy MK et al. Effect of duplicate isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus on antibiogram data. J Clin Microbiol 2003; 41: 4611-6.
8. White RL, Friedrich LV, Burgess DS et al. Effect of removal of duplicate isolates on cumulative susceptibility reports. Diagn Microbiol Infect Dis 2001; 39: 251-6.
9. National Committee for Clinical Laboratory Standards. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data: Proposed Guideline M39-P. NCCLS, Wayne, PA, USA, 2000.
10. Comaglia G, Hryniewicz: W, Jarlier V et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004; 10: 349-83.
11. The Swedish Reference Group for Antibiotics (SRGA). Susceptibillity Testing (SRGA). http://www.srga.org/RAFMETOD/BASMET.HTM (20 January 2007, date last accessed)
12. Veldhuijzen I, Bronzwaer SL, Degener J et al. European Antimicrobial Resistance Surveillance System (EARSS): Susceptibility testing of invasive Staphylococcus aureus. Eufo Surveill 2000; 5: 34-6.
13. Schmitz FJ, Verhoef J, Fluit A. Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. isolates from 20 European university hospitals. SENTRY Participants Group. J Antimicrob Chemother 1999; 43: 431-4.
14. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study. Int J Antimicrob Agents 2003; 22 Suppl 2: 49-52.
15. Osterlund A, Eden T, Olsson-Liljequist B et al. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002; 34: 729-34.
16. Abelson Storby K, Osterlund A, Kahlmeter G. Antimicrobial resistance in Escherichia coli in urine samples from children and adults: A 12 year analysis. Acta Paediatr 2004; 93: 487-91.
17. Sotto A, De Boever CM, Fabbro-Peray P et al. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: A prospective study. J Clin Microbiol 2001; 39: 438-44.
18. Garau J, Xercavins M, Rodriguez-Carballeira M. et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-41.
19. Bruinsma N, Comaglia G, Baquero F et al. Fluoroquinolone resistance in invasive Escherichia coli in Europe is related to age and gender. In: Abstracts of the Fifteenth European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark, 2005 Abstract 1134_04_122. European Society of Clinical Microbiology and Infectious Disease Basel, Switzerland.
20. Landgran M, Oden H, Kuhn I et al. Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries. J Antimicrob Chemother 2005; 55: 928-37.